glp-1 and chronic kidney disease receptor agonists next-generation metabolic hormone therapies in Potential kidney-protective and other effects
Description
Gauge refers to thickness, and the numbers run counterintuitively
Brown, E., Wilding, J
Bring it in the car
Transition periods for compounding pharmacies expired by mid-2025
Agents such as semaglutide and tirzepatide improve metabolic parameters reliably without worsening baseline inflammatory disease activity (95, 96), particularly benefiting patients with coexisting metabolic conditions (98)
The graphical abstract was created using BioRender
